Home›Trial›NCT06685835
🔬NCT06685835Phase 2ACTIVE NOT RECRUITING

A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

Study Summary

The primary purpose of the study is to evaluate the effect of brensocatib compared with placebo.

Conditions
Hidradenitis Suppurativa
Interventions / Drugs
BrensocatibPlacebo
View on ClinicalTrials.gov ↗
Sponsor
INSM
Insmed Incorporated
Rare Disease
F35/100
Study Details
Enrollment214 participants
Primary Completion—
Lead SponsorInsmed Incorporated
Data Retrieved2026-04-11 04:17:39.580882+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.